Marker Therapeutics
Houston, Texas, United States · Biotechnology · 29 employees
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
Funding history
- Venture - Series Unknown — $16.1M — Dec 2024
- Seed — $3.1M — May 2018
- Venture - Series Unknown — $6.2M — Jun 2017
- Seed — $3.1M — Sep 2016
- Seed — $2.4M — Aug 2016
Recent signals
- Dec 30, 2024: Raised $16.1M in Venture - Series Unknown
- May 24, 2018: Raised $3.1M in Seed
- Jun 29, 2017: Raised $6.2M in Venture - Series Unknown
- Sep 09, 2016: Raised $3.1M in Seed
- Aug 23, 2016: Raised $2.4M in Seed
See plans & pricing → Track Marker Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.